Literature DB >> 8831731

Mechanism of selective inhibition of human prostaglandin G/H synthase-1 and -2 in intact cells.

S Kargman1, E Wong, G M Greig, J P Falgueyret, W Cromlish, D Ethier, J A Yergey, D Riendeau, J F Evans, B Kennedy, P Tagari, D A Francis, G P O'Neill.   

Abstract

Selective inhibitors of prostaglandin synthase-2 (PGHS-2) possess potent anti-inflammatory, antipyretic, and analgesic properties but demonstrate reduced side-effects (e.g. gastrotoxicity) when compared with nonselective inhibitors of PGHS-1 and -2. We investigated the mechanism of the differential inhibition of human PGHS-1 (hPGHS-1) and -2 (hPGHS-2) in intact cells by nonsteroidal anti-inflammatory drugs (NSAIDs) and examined factors that contribute to the increased potency of PGHS inhibitors observed in intact cells versus cell-free systems. In intact Chinese hamster ovary (CHO) cell lines stably expressing the hPGHS isozymes, both PGHS isoforms exhibited the same affinity for arachidonic acid. Exogenous and endogenous arachidonic acid were used as substrates by both CHO [hPGHS-1] and CHO [hPGHS-2] cell lines. However, differences were observed in the ability of the hPGHS isoforms to utilize endogenous arachidonic acid released intracellularly following calcium ionophore stimulation or released by human cytosolic phospholipase A2 transiently expressed in the cells. Cell-based screening of PGHS inhibitors demonstrated that the selectivities and potencies of PGHS inhibitors determined using intact cells are affected by substrate concentration and differ from that determined in cell-free microsomal or purified enzyme preparations of PGHS isozymes. The mechanism of inhibition of PGHS isozymes by NSAIDs in intact cells involved difference in their time-dependent inhibition. Indomethacin displayed time-dependent inhibition of cellular hPGHS-1 and -2. In contrast, the selective PGHS-2 inhibitor NS-398 exhibited time-independent inhibition of hPGHS-1 but time-dependent inhibition of hPGHS-2 in intact cells. Reversible inhibition of cellular CHO [hPGHS-1] and CHO [hPGHS-2] was observed with the nonselective NSAIDs ibuprofen and indomethacin, whereas inhibition by the selective PGHS-2 inhibitor DuP-697 was reversible against hPGHS-1 but irreversible against hPGHS-2.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8831731     DOI: 10.1016/0006-2952(96)00462-5

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  15 in total

1.  Inhibition of beta-catenin translocation in rodent colorectal tumors: a novel explanation for the protective effect of nonsteroidal antiinflammatory drugs in colorectal cancer.

Authors:  W A Brown; S A Skinner; D Vogiagis; P E O'Brien
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

2.  Non-steroidal anti-inflammatory drugs with activity against either cyclooxygenase 1 or cyclooxygenase 2 inhibit colorectal cancer in a DMH rodent model by inducing apoptosis and inhibiting cell proliferation.

Authors:  W A Brown; S A Skinner; C Malcontenti-Wilson; D Vogiagis; P E O'Brien
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

3.  Cyclo-oxygenase-2 contributes to constitutive prostanoid production in rat kidney and brain.

Authors:  Pierre-Olivier Hétu; Denis Riendeau
Journal:  Biochem J       Date:  2005-11-01       Impact factor: 3.857

4.  TNF alpha reduces tachykinin, PGE2-dependent, relaxation of the cultured mouse trachea by increasing the activity of COX-2.

Authors:  Ofir Bachar; Andrew C Rose; Mikael Adner; Xudong Wang; Clodagh E Prendergast; Ashley Kempf; Nigel P Shankley; Lars-Olaf Cardell
Journal:  Br J Pharmacol       Date:  2005-01       Impact factor: 8.739

5.  The role of spinal neuropeptides and prostaglandins in opioid physical dependence.

Authors:  Tuan Trang; Maaja Sutak; Remi Quirion; Khem Jhamandas
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

Review 6.  Ibuprofen: pharmacology, efficacy and safety.

Authors:  K D Rainsford
Journal:  Inflammopharmacology       Date:  2009-11-21       Impact factor: 4.473

7.  D-amino acids boost the selectivity and confer supramolecular hydrogels of a nonsteroidal anti-inflammatory drug (NSAID).

Authors:  Jiayang Li; Yi Kuang; Yuan Gao; Xuewen Du; Junfeng Shi; Bing Xu
Journal:  J Am Chem Soc       Date:  2012-11-14       Impact factor: 15.419

8.  The role of cyclooxygenase-1 and cyclooxygenase-2 in lipopolysaccharide and interleukin-1 stimulated enterocyte prostanoid formation.

Authors:  W E Longo; L J Damore; J E Mazuski; G S Smith; N Panesar; D L Kaminski
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

9.  CD36 deficiency leads to choroidal involution via COX2 down-regulation in rodents.

Authors:  Marianne Houssier; William Raoul; Sophie Lavalette; Nicole Keller; Xavier Guillonneau; Barbara Baragatti; Laurent Jonet; Jean-Claude Jeanny; Francine Behar-Cohen; Flavio Coceani; Daniel Scherman; Pierre Lachapelle; Huy Ong; Sylvain Chemtob; Florian Sennlaub
Journal:  PLoS Med       Date:  2008-02       Impact factor: 11.069

10.  In Silico Screening of Nonsteroidal Anti-Inflammatory Drugs and Their Combined Action on Prostaglandin H Synthase-1.

Authors:  Alexey Goltsov; Galina Lebedeva; Ian Humphery-Smith; Gregory Goltsov; Oleg Demin; Igor Goryanin
Journal:  Pharmaceuticals (Basel)       Date:  2010-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.